Amneal Pharmaceuticals (AMRX) Current Assets (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Current Assets of $1.8 billion for Q1 2026, up 19.03% year-over-year from $1.5 billion in Q1 2025, and down 5.93% quarter-over-quarter from $1.9 billion in Q4 2025.
Amneal Pharmaceuticals (AMRX) Current Assets (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Current Assets history runs 10 years deep, the most recent figure standing at $1.8 billion for Q1 2026.
- In Q1 2026, Current Assets rose 19.03% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 19.03% YoY), while the FY2025 annual figure was $1.9 billion, up 20.37% from the prior year.
- Current Assets for Q1 2026 stood at $1.8 billion, down from $1.9 billion in the prior quarter.
- The five-year high for Current Assets was $1.9 billion in Q4 2025, with the low at $1.3 billion in Q1 2023.
- The 5-year median for Current Assets is $1.5 billion (2024), against an average of $1.5 billion.
- The sharpest annual moves came in 2022 and 2025: Current Assets slipped 10.9% in 2022, then grew 21.49% in 2025.
- Amneal Pharmaceuticals' Current Assets stood at $1.4 billion in 2022, then fell by 2.41% to $1.4 billion in 2023, then climbed by 15.24% to $1.6 billion in 2024, then gained by 20.37% to $1.9 billion in 2025, then decreased by 5.93% to $1.8 billion in 2026.
- Business Quant data shows AMRX's Current Assets at $1.8 billion in Q1 2026, $1.9 billion in Q4 2025, and $1.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 1.95 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Bn |
| Mar 31, 2026 | 1.80 Bn |
| Dec 31, 2025 | 1.91 Bn |
| Sep 30, 2025 | 1.84 Bn |
| Jun 30, 2025 | 1.58 Bn |
| Mar 31, 2025 | 1.51 Bn |
| Dec 31, 2024 | 1.59 Bn |
| Sep 30, 2024 | 1.51 Bn |
| Jun 30, 2024 | 1.49 Bn |
| Mar 31, 2024 | 1.38 Bn |
| Dec 31, 2023 | 1.38 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.42 Bn |
| Mar 31, 2023 | 1.31 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.42 Bn |
| Jun 30, 2022 | 1.55 Bn |
| Mar 31, 2022 | 1.39 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.57 Bn |